In murine models, silencing ALKBH5 not only inhibited tumor growth and metastasis but also promoted CD8+ T cell infiltration while reducing the proportion of Tregs and MDSCs, thereby reversing immune resistance via TME modulation (61). Here, ALKBH5 is linked to neoplasm.